With the concerted support of 17 government departments, the latest policies for the biopharmaceutical industry in the Jiangsu Pilot Free Trade Zone have been unveiled!

Release time：

2025-03-01

Recently, the “Policy Measures for Coordinated Support from Relevant Provincial Departments for the Open and Innovative Development of the Biopharmaceutical Industry in the China (Jiangsu) Pilot Free Trade Zone” (hereinafter referred to as the “Policy Measures”) were officially released!

The biopharmaceutical industry is a shared competitive advantage across the three functional zones of the Jiangsu Pilot Free Trade Zone. The Nanjing zone is accelerating the development of “Gene City,” the Suzhou zone ranks first nationwide in biopharmaceutical competitiveness, and the Lianyungang zone leads the nation in innovation output in the biopharmaceutical sector. The Policy Measures focus on the biopharmaceutical industry—this common strength that the three zones are prioritizing—and seek to strengthen systemic integration, coordinated collaboration, and open innovation, with the aim of swiftly establishing the Jiangsu Pilot Free Trade Zone as a nationally leading and internationally recognized hub for biopharmaceutical innovation, a pioneering demonstration zone for institutional openness, and a model for high-quality industrial development.